Sprott Inc’s Inhibikase Therapeutics IKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,667
Closed -$5K 134
2022
Q4
$5K Buy
+1,667
New +$5K ﹤0.01% 134